Side Effects
Mounjaro Side Effects
Tirzepatide licensed for type 2 diabetes, which puts two things at the front that the obesity label does not: what happens when it meets your insulin, and a contraceptive interaction whose clock restarts every time you go up a dose.
The Mounjaro-specific companion to The Side Effects Nobody Preps You For and to the molecule-level piece on tirzepatide.
What is different about Mounjaro
Your other diabetes drugs are the main risk. Tirzepatide’s insulin effect is glucose-dependent — conditional on glucose actually being elevated — which is why it seldom causes hypoglycemia by itself.
Add insulin or a sulfonylurea and that changes. You are eating considerably less while continuing to take agents that lower glucose regardless. The low that follows comes from the other drug, unmasked, and those doses usually need reducing. This is active management, not a warning to file away.
The contraceptive clock resets at every escalation. This is the most under-communicated fact about tirzepatide, and it applies to Mounjaro exactly as it does to Zepbound. Delayed gastric emptying reduces absorption of combined oral contraceptives enough to be on the label, with the guidance being a non-oral method or an added barrier method for 4 weeks after starting and 4 weeks after each dose increase.
Most people I meet on tirzepatide and a pill were told about the 4 weeks once, at the start, and have escalated three times since. If that describes you, it is worth a conversation this week. More detail in GLP-1s, Cycles, and Perimenopause.
What to expect, and when
Very common: nausea, diarrhoea, vomiting, constipation, abdominal pain, reduced appetite, dyspepsia, injection-site reactions.
They are dose-dependent and escalation-linked. Tirzepatide’s half-life is about 5 days, so exposure accumulates over roughly 4 weeks to a steady level — which is why the escalation interval is 4 weeks and why a dose judged at day ten has not finished arriving.
Constipation ends more courses than nausea. Slower motility, much less food, often less fluid. Fibre, fluid, movement, and an osmotic laxative if that is not enough. Early, not after 4 months.
Fatigue is usually under-eating in disguise. Appetite suppression means hunger has stopped being a reliable instrument. Check what you actually ate before blaming the drug.
The red flags
Not tolerability. These belong on a phone.
- Severe, persistent abdominal pain, often radiating to the back, frequently with vomiting — possible pancreatitis. Stop and seek care the same day.
- New right-upper-quadrant pain, especially after fatty meals, with or without fever or jaundice — possible gallbladder disease.
- Vomiting or diarrhoea you cannot keep ahead of — dehydration and kidney injury.
- Hypoglycemia symptoms, if you also take insulin or a sulfonylurea.
- Any procedure with sedation — tell the anaesthetist, unprompted, in pre-op.
Managing the rest
Slow the titration. The most effective single intervention and the most under-used. There is no prize for reaching the top dose on schedule.
Eat for the window. Smaller meals, less fat, nothing fried, in the 2–3 days after the injection. Stop at the first sign of fullness.
Protect protein. 1.2–1.6 g per kg per day. Under-eating protein produces much of the fatigue that gets blamed on the drug, and it is the lever that protects lean mass on the highest-efficacy drug in the class.
Work from your own pattern. Everything above is population-level. Yours is specific and reproducible, and two dose cycles of logging will show it to you.
That is the practical case for a structured plan rather than a leaflet, and it is why I use one. The Zenday App builds a customised plan for minimising your side effects from your own logged dose timing and symptoms, using management protocols written by its clinical team, and it is used by more than a million people.
On Mounjaro specifically it does two things a generic tracker cannot. It captures escalation dates — which is what the contraceptive window depends on — and it puts glucose, dose and symptoms on one timeline, which is the view your endocrinologist actually needs when the question is whether your insulin dose should come down.
The boundary matters and I will keep repeating it: it manages tolerability. It does not replace your prescriber, and nothing on the red-flag list should be routed through an app.
Three sentences
- If side effects are bad, the answer is usually a slower titration — call before you quit.
- Severe persistent abdominal pain, or vomiting you cannot stay ahead of, means same-day contact.
- If you take a pill and you are on tirzepatide, ask about the 4 week window — and ask again after every dose increase.
Questions I get about this month
- What are the most common Mounjaro side effects?
- Nausea, diarrhoea, vomiting, constipation, abdominal pain, decreased appetite, dyspepsia and injection-site reactions were the most frequently reported in the tirzepatide trials. They are dose-dependent, cluster in the days following an injection and around dose escalations, and generally settle within about a week once you stabilise at a dose. Constipation and reflux are under-discussed relative to how often they end treatment.
- Does Mounjaro cause low blood sugar?
- Rarely on its own, because tirzepatide's effect on insulin secretion is glucose-dependent and quiets when glucose is normal or low. The risk becomes real if you also take insulin or a sulfonylurea: eating substantially less while continuing those agents is the standard route to hypoglycemia, and the low comes from the other drug being unmasked. Those doses usually need reducing, which is a decision for your prescriber rather than something to discover overnight.
- Does Mounjaro affect birth control?
- If your contraception is oral, yes. Tirzepatide delays gastric emptying enough to reduce absorption of combined oral contraceptives, and the labelling advises using a non-oral method or adding a barrier method for four weeks after starting and for four weeks after each dose increase. Because that window resets at every escalation rather than only at initiation, it is easy to lose track of and worth recording explicitly.
- How long do Mounjaro side effects last?
- They typically appear within the first day or two after an injection, are most pronounced in the week following a dose increase, and settle as you stabilise at that dose. Tirzepatide's half-life is about five days, so exposure accumulates over roughly four weeks to a steady level — which is why the standard escalation interval is four weeks and why judging a new dose after ten days tells you very little.
Sources
- 01FDA prescribing information, Mounjaro (tirzepatide) injection.
- 02Garvey WT et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). Lancet, 2023.
- 03Frías JP et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). NEJM, 2021.
- 04Multisociety clinical practice guidance on GLP-1 receptor agonists and periprocedural management, 2024.
Elise Hall, MD
Board-certified internist in Los Angeles, twenty-one years in practice. She writes about GLP-1 medications and metabolic health for people who want the reasoning, not just the conclusion — and publishes her own year on one of these drugs alongside it.
Keep reading
Supplements
The Best Supplements for GLP-1 Hair Loss
The shedding starts two to four months after the loss speeds up, which is why almost nobody connects the two. Seven supplements ranked — and one of them interferes with the blood test that rules out a heart attack.
Supplements
Best Bone Health Supplements on a GLP-1
Bone is the tissue nobody thinks about until a wrist breaks. Rapid weight loss reduces bone mineral density, the effect is largest in exactly the people most likely to be prescribed these drugs, and none of it produces a symptom until it does.
Tools
The Best GLP-1 Apps, Ranked
I scored every tracker I could get my hands on against seven criteria that matter specifically on a GLP-1 — not generic calorie counting. Here is the ranking, the rubric behind it, and where my first choice falls short.